Shire sets up shop near competitor Genzyme; Meridian turns to IT for ops improvement;

> Shire, which won a speedy approval for its Gaucher disease drug earlier this year thanks to manufacturing woes at Genzyme's Boston-area plant, is building a 1,500-employee manufacturing and research campus in Lexington, MA. Article

> Meridian Enterprises has selected the Blue Star Infotech integrated business management and information system, Elixir, to resolve operational issues. Item

> Raw materials supplier Kern Pharma is now using the Alfresco enterprise content management (ECM) system for document and records management, including generation of electronic records. Release

> Cannabis Science is expanding internal production capabilities at its recently acquired cannabis provider, Montana Pain Management. Release

> David Gelber has been named director for manufacturing at Avrio Biopharmaceuticals, a California-based contract manufacturer. Release

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.